484 related articles for article (PubMed ID: 29556350)
21. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
[TBL] [Abstract][Full Text] [Related]
22. Glutathione-Activated NO-/ROS-Generation Nanoparticles to Modulate the Tumor Hypoxic Microenvironment for Enhancing the Effect of HIFU-Combined Chemotherapy.
Li Q; Zhang J; Li J; Ye H; Li M; Hou W; Li H; Wang Z
ACS Appl Mater Interfaces; 2021 Jun; 13(23):26808-26823. PubMed ID: 34085524
[TBL] [Abstract][Full Text] [Related]
23. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors.
Ding Y; Cui W; Sun D; Wang GL; Hei Y; Meng S; Chen JH; Xie Y; Wang ZQ
Drug Des Devel Ther; 2017; 11():3105-3117. PubMed ID: 29123382
[TBL] [Abstract][Full Text] [Related]
24. Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency.
Chen WL; Yang SD; Li F; Li JZ; Yuan ZQ; Zhu WJ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2016 Sep; 511(2):728-40. PubMed ID: 27484835
[TBL] [Abstract][Full Text] [Related]
25. Bacterial microbots for acid-labile release of hybrid micelles to promote the synergistic antitumor efficacy.
Xie S; Chen M; Song X; Zhang Z; Zhang Z; Chen Z; Li X
Acta Biomater; 2018 Sep; 78():198-210. PubMed ID: 30036720
[TBL] [Abstract][Full Text] [Related]
26. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
Li W; Sun X
Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
Han Y; Zhang P; Chen Y; Sun J; Kong F
Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
[TBL] [Abstract][Full Text] [Related]
28. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
29. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
[TBL] [Abstract][Full Text] [Related]
30. Featured Article: Chemotherapeutic delivery using pH-responsive, affinity-based release.
Cyphert EL; Fu AS; von Recum HA
Exp Biol Med (Maywood); 2017 Apr; 242(7):692-699. PubMed ID: 28178856
[TBL] [Abstract][Full Text] [Related]
31. LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.
Fan S; Niu Y; Tan N; Wu Z; Wang Y; You H; Ke R; Song J; Shen Q; Wang W; Yao G; Shu H; Lin H; Yao M; Zhang Z; Gu J; Qin W
Oncogene; 2013 Mar; 32(13):1682-90. PubMed ID: 22580606
[TBL] [Abstract][Full Text] [Related]
32. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
[TBL] [Abstract][Full Text] [Related]
33. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
34. Intestinal probiotics
He L; Yang H; Tang J; Liu Z; Chen Y; Lu B; He H; Tang S; Sun Y; Liu F; Ding X; Zhang Y; Hu S; Xia L
J Biol Eng; 2019; 13():58. PubMed ID: 31297149
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of a biomaterial-based anticancer drug delivery system as an alternative to conventional post-surgery bone cancer treatment.
Bischoff I; Tsaryk R; Chai F; Fürst R; Kirkpatrick CJ; Unger RE
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():115-124. PubMed ID: 30274043
[TBL] [Abstract][Full Text] [Related]
36. Targeted multidrug delivery system to overcome chemoresistance in breast cancer.
Tang Y; Soroush F; Tong Z; Kiani MF; Wang B
Int J Nanomedicine; 2017; 12():671-681. PubMed ID: 28176940
[TBL] [Abstract][Full Text] [Related]
37. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
[TBL] [Abstract][Full Text] [Related]
38. Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug.
MacDiarmid JA; Amaro-Mugridge NB; Madrid-Weiss J; Sedliarou I; Wetzel S; Kochar K; Brahmbhatt VN; Phillips L; Pattison ST; Petti C; Stillman B; Graham RM; Brahmbhatt H
Nat Biotechnol; 2009 Jul; 27(7):643-51. PubMed ID: 19561595
[TBL] [Abstract][Full Text] [Related]
39. RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy
Gao J; Wang S; Dong X; Wang Z
Theranostics; 2021; 11(7):3301-3316. PubMed ID: 33537088
[No Abstract] [Full Text] [Related]
40. Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy.
Wang T; Yin Q; Huang HY; Wang Z; Song H; Luo X
Colloids Surf B Biointerfaces; 2023 May; 225():113277. PubMed ID: 36996630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
